VIVUS, Inc. Board and Management Team Successfully Executing Plan to Unlock the Full Potential of Qsymia

Published: Jul 09, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MOUNTAIN VIEW, Calif., July 9, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) (the "Company"), a pharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, today responded to First Manhattan Co.'s (FMC) July 2, 2013 open letter to VIVUS stockholders:

Help employers find you! Check out all the jobs and post your resume.

Back to news